ACQUIREDT+2
Bedrosian Camille L
Amylyx Pharmaceuticals Inc · NASDAQ
+22,807 sh
Filed 20 Aug 2026SEC Form 4view source
BlackRock
13F filer
$5.1M
2,669,741 sh
Two Sigma Investments
13F filer
$2.3M
161,945 sh
Bedrosian Camille L
US insider
—
22,807 sh
Frates James M
US insider
—
22,807 sh
Klee Justin B.
US insider
—
60,039 sh
Mazzariello Gina
US insider
—
21,284 sh
Cohen Joshua B
US insider
—
60,039 sh
Bedrosian Camille L
Amylyx Pharmaceuticals Inc · NASDAQ
+22,807 sh
Klee Justin B.
Amylyx Pharmaceuticals Inc · NASDAQ
+60,039 sh
Mazzariello Gina
Amylyx Pharmaceuticals Inc · NASDAQ
+21,284 sh
Frates James M
Amylyx Pharmaceuticals Inc · NASDAQ
+22,807 sh
Cohen Joshua B
Amylyx Pharmaceuticals Inc · NASDAQ
+60,039 sh
Two Sigma Investments
Amylyx Pharmaceuticals Inc · NASDAQ
161,945 sh · $2.3M
BlackRock
Amylyx Pharmaceuticals Inc · NASDAQ
2,669,741 sh · $5.1M